Pulmonx Reports Second Quarter 2025 Financial Results
Provided By GlobeNewswire
Last update: Jul 30, 2025
REDWOOD CITY, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported financial results for the second quarter of 2025 ended June 30, 2025.
Read more at globenewswire.com1.61
-0.23 (-12.5%)
Find more stocks in the Stock Screener
LUNG Latest News and Analysis
